Visa tops Q4 Street estimates, Guides for FY18
Credit card provider, Visa Inc. (NYSE: V) reported better than anticipated fiscal 2017 fourth-quarter earnings on October 25. On the basis of an improved global economic outlook, the company also issued an impressive revenue growth outlook.
Thus, following the results, the stock has gained about 3% so far to trade at $111 levels. We expect the uptrend to continue in the days ahead due to the facts presented below.
The Foster City, California-based company reported Q4 2017 revenues of $4.855 billion, up from $4.26 billion in the similar quarter last year.
During the fourth-quarter, net income increased to $2.14 billion, or $0.90 per share (Class A), from $1.93 billion, or $0.79 per share (Class A) in the fourth-quarter last year. The Street analysts had expected Visa to report earnings of $0.86 per share on revenues of $4.62 billion.
Services revenue increased $168 million y-o-y to $2.116 billion in the final quarter of fiscal 2017. Data processing revenues were $2.067 billion, an increase of $83 million from $1.984 billion last year. International transaction revenues were $1.792 billion, compared with $1.571 billion in the year-ago period.
Visa’s payments volume grew 9.8% y-o-y to $1.93 trillion on a constant dollar basis. Nearly 43% of the volume came from the US. Cross-border volume growth increased by 10% in the quarter ended September 2017. Total processed transactions were $29.20 billion, up 13% on a year-over- year basis.
The company ended September quarter with cash and cash equivalents of $9.874 billion, up from $5.679 billion in the corresponding quarter of fiscal 2016.
Visa also issued its outlook for fiscal 2018. The company expects a high single digit net revenue growth, with positive foreign currency impact ranging from 0.5% to 1%. The annual operating margin is expected to be in the high 60s. A tax rate of about 29% is anticipated.
The stock is moving along an ascending channel as shown in the image below. Further, the MACD indicator is moving above the zero line, while the accumulation indicator is rising. Thus, we expect the stock to remain in an uptrend.
To benefit from the uptrend, we are looking at the possibility of acquiring a call option from a dependable binary broker. The option should remain valid for a period of seven trading days. Further, the stock should be trading near $111 in the NYSE.
Bank share values in the UK took something of a hit yesterday with the announcement that up to 2 million
The shares of point-of- care blood analyzer provider Abaxis Inc (ABAX) was hammered by investors last week, following a report